Page 2 of Novartis

Novartis, Novartis phase 3 trial, chronic hives, allergy, healthcare news, pharma news,

Novartis’ oral drug shows promising results for chronic hives treatment in Phase III trials

Data are being presented at the 2023 American College of Allergy, Asthma and Immunology Scientific Meeting in Anaheim, California, November…

November 10, 2023 13:08 IST

Novartis, Novartis drug, Cosentyx, chronic skin condition, healthcare news,

USFDA approves Novartis’ new drug for patients with chronic skin disease; Becomes first approved biologic drug for this condition in a decade

Hidradenitis suppurativa (HS) is a chronic, systemic and often painful skin disease that causes recurring boil-like lumps that may burst…

November 1, 2023 14:26 IST

Novartis, Kidney disease, nephropathy, healthcare news, pharma news,

Novartis’ investigational drug to treat kidney disease demonstrates promising results in Phase III study

The addition of these two late-stage medicines, as well as an early-stage pipeline, expands the Novartis renal portfolio.

October 30, 2023 12:16 IST

Sandoz starts share trading on SIX Swiss Exchange as independent company after 100 percent spin-off from Novartis

Generics and biosimilars account for an estimated 80 percent of medicines used worldwide by volume, at about 25 percent of…

October 4, 2023 12:16 IST

Novartis executes Sandoz Spin-off; To ‘fully’ focus on innovative medicines

With its new strategy unveiled in 2022, Novartis has now transformed into a focused innovative medicines business, concentrated on four…

October 4, 2023 11:09 IST

healthcare revolution, health news, pharma news,

Sandoz gets positive CHMP opinion for its multiple sclerosis biosimilar

Multiple sclerosis (MS) is a chronic, inflammatory, and neurodegenerative disease of the central nervous system (brain and spinal cord) caused…

July 24, 2023 11:09 IST

Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs

Reportedly, Novartis which is also named in this complaint is preparing to spin Sandoz off into a standalone company later…

May 3, 2023 12:05 IST

Vasant Narasimhan, CEO Novartis, Vasant Narasimhan salary, Vasant Narasimhan net worth, who is Vasant Narasimhan, Vasant Narasimhan lifestyle, Vasant Narasimhan education

Meet Vasant Narasimhan, the CEO of Novartis who earns Rs 20 lakh per day; Know about his lifestyle, education and family

Vasant Narasimhan took over control at the Swiss MNC Novartis in 2018.

Updated: March 26, 2023 10:24 IST

Novartis, Brain cancer, pediatric cancer, healthcare news, pharma news,

USFDA approves Novartis’ combination targeted therapy for pediatric brain cancer

These data were highlighted as part of an official press briefing and oral presentation at the 2022 American Society of…

March 17, 2023 11:36 IST

GlobalData, Rare Diseases, China market, healthcare news, pharma news,

Sandoz signs MoU to build new biologics production plant in Slovenia; To support increasing global demand for biosimilar medicines

Work on the new plant is set to begin this year, with full operations provisonally planned for late 2026.

March 10, 2023 12:54 IST

Novartis appoints Gilbert Ghostine as Chairman-Designate of Sandoz Board of Directors

He currently serves on two boards of directors; at Danone, where he is a member of the audit committee, and…

February 20, 2023 11:54 IST

Rare Diseases, Ministry of Health, Ministry of Finance, Rare Diseases Treatment, Custom Duty, Healthcare news,

Mankind Pharma reduces price of its heart failure drug by 70 percent in India

Studies show that heart failure claims more than 17.9 million lives every year globally whilst, medicines for critically ill heart…

January 25, 2023 12:39 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

Sandoz announces agreement to acquire leading antifungal agent from Astellas

The announcement comes after Sandoz successfully completed the acquisition of GSK’s global cephalosporins portfolio in October 2021.

January 24, 2023 11:40 IST

Lupin launches generic version of Novartis’ heart failure drug in India

Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…

January 18, 2023 18:42 IST

Novartis, Heart failure, patent expiry, Indian cardiac market, healthcare news, pharma news,

Novartis’ heart failure drug to go off patent this month; Will this make cardiac care in India affordable?

The affordable versions of the blockbuster drug are expected to hit the market this month and reportedly reduce the cost…

January 15, 2023 16:05 IST

Novartis’ investigational drug shows positive outcomes in patients with rare blood disorder

Detailed data will be presented at an upcoming medical meeting and included as part of global regulatory submissions in 2023,…

December 8, 2022 13:12 IST

Novartis’ bad cholesterol drug shows ‘sustained’ efficacy and safety among cardiac patients

According to the company, Leqvio is the first and only small interfering RNA (siRNA) therapy to lower LDL-C and is…

November 8, 2022 11:28 IST

Novartis, Sandoz, essential antibiotics, antibiotics demands, health news, pharma news,

Sandoz to support increased global demand for essential antibiotics; Announces additional investment in manufacturing facility in Austria

The expansion will support a double-digit increase in our future output capacity for penicillins, the company claims.

November 7, 2022 16:45 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

Green Cards, H-1B visas, F-Visa, foreign students, US Visa fees, legal immigration

US tightens rules for Green Cards and H-1B visas

‘More anticlimactic than shocking’: IT professional in late 40s opens up about layoff, says ‘it was only a matter of…’

Who is Prince Hisahito? First male in world’s oldest monarchy in 40 years

Life1 hr ago

Japan’s 2,600-year-old monarchy has just crowned 19-year-old Prince Hisahito as their heir, bringing hope to the succession crisis. Hisahito, the nephew of Emperor Naruhito, is now second in line to the throne and has a strong interest in biology and dragonflies. Japan’s male succession rules have been in place since 1947, but there is growing support for changing the laws.

View all shorts